Re: biotest news release today
Yes, understood "it is in a MOUSE model"; but if you have a disease for which SOC fails to perform, and doctors are running out of ideas as to how to treat you, I venture to say:
"a MOUSE model is better than NO model" and by the way, Biotest started to evaluate this agent in "people" with Relapsed or Refractory Multiple Myeloma back in 2009.
If you happen to fall in a category for which treatment options are severely restricted and your chances of survival are slim or next to none, then it's time for governing authorities to become co-creative and help in making solutions available. One such way would be by seriously reducing the volumes of red-tape, new, promising products are subjected to.